Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer
In conclusion, TDLN represent a rich source of polyclonal HPV16 E6- and E7-specific T cells, which can be expanded under clinical grade conditions for adoptive immunotherapy in patients wi th cervical cancer.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Cervical Cancer | Genital Warts | Human Papillomavirus (HPV) | Immunotherapy